Q32 Bio (QTTB) EBT Margin Growth (1y) (2019 - 2023)
Q32 Bio (QTTB) EBT Margin Growth (1y) (2019 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-1,532.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,558.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Q32 Bio |
167.59 Mn |
116.84 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2023 |
609,119.00 |
| Sep 30, 2023 |
318,801.00 |
| Jun 30, 2023 |
328,926.00 |
| Mar 31, 2023 |
-1.19 Mn |
| Dec 31, 2022 |
6,783.00 |
| Sep 30, 2022 |
-211,411.00 |
| Jun 30, 2022 |
-207,584.00 |
| Mar 31, 2022 |
1.17 Mn |
| Dec 31, 2021 |
-114,751.00 |
| Sep 30, 2021 |
315,402.00 |
| Jun 30, 2021 |
483,820.00 |
| Mar 31, 2021 |
600,501.00 |
| Dec 31, 2020 |
125,264.00 |
| Sep 30, 2020 |
173,895.00 |
| Jun 30, 2020 |
46,873.00 |
| Mar 31, 2020 |
282,540.00 |
| Dec 31, 2019 |
-272,180.00 |
| Sep 30, 2019 |
-583,499.00 |
| Jun 30, 2019 |
-581,078.00 |
| Mar 31, 2019 |
-792,911.00 |
